PE20152019A1 - Formulaciones y metodos para aumentar la produccion de proteinas recombinantes - Google Patents
Formulaciones y metodos para aumentar la produccion de proteinas recombinantesInfo
- Publication number
- PE20152019A1 PE20152019A1 PE2015001799A PE2015001799A PE20152019A1 PE 20152019 A1 PE20152019 A1 PE 20152019A1 PE 2015001799 A PE2015001799 A PE 2015001799A PE 2015001799 A PE2015001799 A PE 2015001799A PE 20152019 A1 PE20152019 A1 PE 20152019A1
- Authority
- PE
- Peru
- Prior art keywords
- cells
- recombinant protein
- formulations
- methods
- protein production
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/12—Light metals, i.e. alkali, alkaline earth, Be, Al, Mg
- C12N2500/14—Calcium; Ca chelators; Calcitonin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/34—Sugars
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Medicinal Chemistry (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
SE REFIERE A FORMULACIONES PARA MEDIOS DE CULTIVO DE CELULAS DE MAMIFERO QUE EXPRESAN PROTEINAS RECOMBINANTES, QUE COMPRENDEN AL MENOS 3.5 g/L O MAS DE MANOSA, O DE 1.5 mM A 9.5 mM DE CALCIO. TAMBIEN SE REFIERE A METODOS PARA PRODUCIR PROTEINAS RECOMBINANTES, QUE COMPRENDEN CULTIVAR CELULAS QUE EXPRESAN LA PROTEINA RECOMBINANTE, EN UN MEDIO DE CULTIVO DE CELULAS QUE INCLUYE AL MENOS 3.5 g/L O MAS DE MANOSA, O DE 1.5 mM A 9.5 mM DE CALCIO. EN UN ASPECTO PREFERIDO, LAS CELULAS DE MAMIFERO SE SELECCIONAN ENTRE CELULAS BHK, CELULAS CHO, CELULAS HKB, CELULAS HEK Y CELULAS NS0. EN OTRO ASPECTO PREFERIDO, LA PROTEINA RECOMBINANTE ES EL FACTOR RECOMBINANTE HUMANO VIII (rhFVIII) O UNA VARIANTE DEL MISMO
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361769402P | 2013-02-26 | 2013-02-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20152019A1 true PE20152019A1 (es) | 2016-01-29 |
Family
ID=50240092
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2015001799A PE20152019A1 (es) | 2013-02-26 | 2014-02-25 | Formulaciones y metodos para aumentar la produccion de proteinas recombinantes |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US20160002592A1 (es) |
| EP (1) | EP2961827A1 (es) |
| JP (1) | JP2016508376A (es) |
| KR (1) | KR20150121701A (es) |
| CN (1) | CN105308174A (es) |
| AR (1) | AR094875A1 (es) |
| AU (1) | AU2014223680A1 (es) |
| BR (1) | BR112015020253A2 (es) |
| CA (1) | CA2902170A1 (es) |
| EA (1) | EA201591558A1 (es) |
| HK (1) | HK1220991A1 (es) |
| IL (1) | IL240639A0 (es) |
| MX (1) | MX2015010887A (es) |
| PE (1) | PE20152019A1 (es) |
| SG (1) | SG11201506212PA (es) |
| TW (1) | TW201522634A (es) |
| UY (1) | UY35343A (es) |
| WO (1) | WO2014134071A1 (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9481901B2 (en) | 2013-05-30 | 2016-11-01 | Amgen Inc. | Methods for increasing mannose content of recombinant proteins |
| EP3409783B1 (de) * | 2017-06-01 | 2020-12-16 | Justus-Liebig-Universität Gießen | Erfindung betreffend detektion und quantifizierung von colistin-resistenz bei gram-negativen bakterien |
| CN112006522B (zh) * | 2019-05-31 | 2022-01-28 | 佛山市顺德区美的电热电器制造有限公司 | 烹饪器具、用于烹饪器具的烹饪附件以及控制方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6238891B1 (en) * | 1987-11-18 | 2001-05-29 | Cetus Oncology Corporation | Method of increasing product expression through solute stress |
| WO1993022448A1 (en) * | 1992-05-01 | 1993-11-11 | Teijin Limited | Fed batch culture method for protein secreting cells |
| CN101198621A (zh) * | 2005-01-25 | 2008-06-11 | 阿波罗生命科学有限公司 | 分子及其嵌合分子 |
| WO2006079155A1 (en) * | 2005-01-25 | 2006-08-03 | Apollo Life Sciences Limited | Molecules and chimeric molecules thereof |
| DE102005046225B4 (de) * | 2005-09-28 | 2012-01-05 | Cellca Gmbh | Verbessertes Zellkulturmedium |
| WO2008128228A1 (en) * | 2007-04-16 | 2008-10-23 | Momenta Pharmaceuticals, Inc. | Methods related to cell surface glycosylation |
| GB0915481D0 (en) * | 2009-09-04 | 2009-10-07 | Arecor Ltd | Stable manufacture of factor V111 |
| WO2011127380A2 (en) * | 2010-04-09 | 2011-10-13 | Fox Chase Cancer Center | Compositions and methods for the prevention of cancer in high risk patients |
| SG10201809632XA (en) * | 2010-07-08 | 2018-12-28 | Baxalta Inc | METHOD OF PRODUCING RECOMBINANT HIGH MOLECULAR WEIGHT vWF IN CELL CULTURE |
| WO2012007324A2 (en) * | 2010-07-15 | 2012-01-19 | Novo Nordisk A/S | Stabilized factor viii variants |
-
2014
- 2014-02-21 UY UY0001035343A patent/UY35343A/es not_active Application Discontinuation
- 2014-02-24 TW TW103105992A patent/TW201522634A/zh unknown
- 2014-02-24 AR ARP140100579A patent/AR094875A1/es unknown
- 2014-02-25 EP EP14709147.4A patent/EP2961827A1/en not_active Withdrawn
- 2014-02-25 MX MX2015010887A patent/MX2015010887A/es unknown
- 2014-02-25 SG SG11201506212PA patent/SG11201506212PA/en unknown
- 2014-02-25 CN CN201480010579.8A patent/CN105308174A/zh active Pending
- 2014-02-25 JP JP2015559286A patent/JP2016508376A/ja active Pending
- 2014-02-25 WO PCT/US2014/018428 patent/WO2014134071A1/en active Application Filing
- 2014-02-25 EA EA201591558A patent/EA201591558A1/ru unknown
- 2014-02-25 PE PE2015001799A patent/PE20152019A1/es not_active Application Discontinuation
- 2014-02-25 BR BR112015020253A patent/BR112015020253A2/pt not_active IP Right Cessation
- 2014-02-25 US US14/770,064 patent/US20160002592A1/en not_active Abandoned
- 2014-02-25 KR KR1020157022820A patent/KR20150121701A/ko not_active Withdrawn
- 2014-02-25 CA CA2902170A patent/CA2902170A1/en not_active Abandoned
- 2014-02-25 AU AU2014223680A patent/AU2014223680A1/en not_active Abandoned
-
2015
- 2015-08-18 IL IL240639A patent/IL240639A0/en unknown
-
2016
- 2016-08-01 HK HK16109114.4A patent/HK1220991A1/zh unknown
-
2017
- 2017-09-08 US US15/699,088 patent/US20180010090A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| BR112015020253A2 (pt) | 2017-07-18 |
| TW201522634A (zh) | 2015-06-16 |
| HK1220991A1 (zh) | 2017-05-19 |
| JP2016508376A (ja) | 2016-03-22 |
| IL240639A0 (en) | 2015-09-24 |
| CN105308174A (zh) | 2016-02-03 |
| AU2014223680A1 (en) | 2015-09-17 |
| SG11201506212PA (en) | 2015-09-29 |
| AR094875A1 (es) | 2015-09-02 |
| UY35343A (es) | 2014-09-30 |
| MX2015010887A (es) | 2015-12-01 |
| WO2014134071A1 (en) | 2014-09-04 |
| US20160002592A1 (en) | 2016-01-07 |
| US20180010090A1 (en) | 2018-01-11 |
| EA201591558A1 (ru) | 2016-03-31 |
| EP2961827A1 (en) | 2016-01-06 |
| CA2902170A1 (en) | 2014-09-04 |
| KR20150121701A (ko) | 2015-10-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2016003096A1 (es) | Métodos para cosechar cultivos de células de mamífero | |
| CU20200089A7 (es) | Moléculas de unión contra bcma | |
| MX2021014007A (es) | Proteinas de union a epcam y metodos de uso. | |
| MX2020009326A (es) | Anticuerpos anti-claudina 18.2 y usos de los mismos. | |
| EA202091333A1 (ru) | Способы активации, модификации и экспансии t-клеток для лечения рака и связанных с ним злокачественных заболеваний | |
| CY1124778T1 (el) | Αντισωματα anti-asic1 και χρησεις αυτων | |
| AR121305A2 (es) | Proteínas encapsulantes de lípidos neutros modificadas y sus usos | |
| EA202090931A2 (ru) | Композиции и способы перепрограммирования tcr с помощью гибридных белков | |
| CO2017000507A2 (es) | Receptor quimérico de antígeno bcma | |
| BR112015013525A2 (pt) | método para produção de uma proteína de fusão, bem como composição compreendendo uma proteína de fusão | |
| MX2018011105A (es) | Inhibidores sustituidos de menina-mll y metodos de uso. | |
| UY33826A (es) | Proteínas de unión con dominios trivariables y sus usos | |
| UY32812A (es) | Anticuerpos humanos de alta afinidad para angiopoyetina -2 humana. | |
| AR105602A1 (es) | Medio de cultivo celular suplementado con taurina y métodos de utilización | |
| PE20150645A1 (es) | Proteinas de fusion de interleuquina 10 y usos de las mismas | |
| AR094375A1 (es) | Métodos de uso de inhibidores del ciclo celular para modular una o más propiedades de un cultivo celular | |
| CO7051009A2 (es) | Composiciones del factor viii y métodos para hacerlas y usarlas | |
| CR20120026A (es) | Construcciones novedosas de proteína del virus de papiloma humano (hpv) y su uso en la prevención de la enfermedad por el hpv | |
| EA202091349A1 (ru) | Способы культивирования клеток | |
| MX2019008872A (es) | Prevencion y tratamiento de da?o o enfermedad osea y cartilago. | |
| UY38701A (es) | Moléculas de unión a cd19, conjugados, composiciones que las comprenden y usos de las mismas | |
| MX2017001285A (es) | Anticuerpos anti-huntingtina (htt) derivados de humano y usos de los mismos. | |
| AR113492A2 (es) | Furina recombinante libre de proteínas sustancialmente animal y métodos para producirla | |
| MX2016013631A (es) | Celulas huespedes modificadas y usos de las mismas. | |
| MX377780B (es) | Sobreexpresion de reguladores de la ruta de n-glicosilacion para modular la glicosilacion de proteinas recombinantes. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application declared void or lapsed |